GLYCOTOPE GmbH Company Profile

08:57 EDT 19th March 2018 | BioPortfolio

GLYCOTOPE GmbH is a biotechnology company specialized in Glycobiology and Cellular Engineering. GLYCOTOPE combines its expertise in drug development, analytics, glycobiology, cell biology, molecular biology, biotechnology, antibody engineering and immunology to develop own innovative pharmaceutical therapeutics and nutrition additives and to offer state-of-the art services.
GLYCOTOPE business activities focus on customized services in Protein Expression, GlycoEngineering and GlycoAnalytics. GLYCOTOPE has developed cellular and molecular glycosylation platforms and offers a full range of glycoanalytical techniques in-house and in combination with a network of specialists.


Robert-Rössle-Str. 10


Phone: 49-30-941084-184
Fax: 49-30-941084-188

News Articles [127 Associated News Articles listed on BioPortfolio]

Daiichi Sankyo & Glycotope Enter Option Agreement for Antibody Drug Conjugate Strategic Collaboration and Licensing

TOKYO and BASKING RIDGE, N.J., and BERLIN, Oct. 30, 2017 /PRNewswire/ — Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Glycotope GmbH (hereafter, Glycotope) have signed an optio...

Daiichi Sankyo, Glycotope Enter Strategic ADC Alliance

To develop ADC combining Daiichi's ADC technology with Glycotope's investigational TA-MUC1 antibody

Swiss CDMO to expand newly bought Glycotope biomanufacturing plant in Germany

Celonic says it will immediately begin expanding the former Glycotope site in Heidelberg, Germany adding two 2,000L single-use bioreactors.

BRIEF—Celonic acquires Glycotope’s bio-manufacturing facility

Celonic, a Swiss global biologics development and manufacturing services provider, and Berlin-based Glycotope,…

Daiichi Sankyo inks Glycotope ADC deal

Daiichi Sankyo Company has signed an option agreement to develop Glycotopeâs antibody drug conjugate (ADC) to target various cancers including ovarian, lung and breast tumours.

Celonic acquires Glycotope’s bio-manufacturing plant in Germany

Celonic, a privately owned CDMO based in Basel, Switzerland, has completed the acquisition of Glycotope’s bio-manufacturing facility in Heidelberg, Germany.

Daiichi, Glycotope partner for cancer ADC

Celonic Acquires Glycotope’s Bio-Mfg. Facility in Heidelberg

Expands GMP manufacturing assets and capacity for late-stage and commercial supply

PubMed Articles [16 Associated PubMed Articles listed on BioPortfolio]

Differential recognition of natural and remodeled glycotopes by three Diocleae lectins.

The carbohydrate specificities of Dioclea grandiflora lectins DGL-I1 and DGL-II, and Galactia lindenii lectin II (GLL-II) were explored by use of remodeled glycoproteins as well as by the lectin hemag...

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Postoperative Corneal Asphericity in Low, Moderate, and High Myopic Eyes After Transepithelial PRK Using a New Pulse Allocation.

To evaluate the postoperative asphericity in low, moderate, and high myopic eyes after combined transepithelial photorefractive keratectomy and SmartSurfACE treatment (SCHWIND eye-tech-solutions GmbH,...

Clinical Trials [41 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Telemedical Examination of a Three-Component Oculomotor Testing Battery

The study investigates the feasibility and safety of the telemedical implementation of three diagnostic oculomotor tests using a video-oculography device and an extended teleconferencing s...

Companies [527 Associated Companies listed on BioPortfolio]


GLYCOTOPE GmbH is a biotechnology company specialized in Glycobiology and Cellular Engineering. GLYCOTOPE combines its expertise in drug development, analytics, glycobiology, cell biology, molecular b...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "GLYCOTOPE GmbH" on BioPortfolio

We have published hundreds of GLYCOTOPE GmbH news stories on BioPortfolio along with dozens of GLYCOTOPE GmbH Clinical Trials and PubMed Articles about GLYCOTOPE GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GLYCOTOPE GmbH Companies in our database. You can also find out about relevant GLYCOTOPE GmbH Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record